Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin

Urology

Volumn 68, Issue 4, 2006, Pages 862-865

  Van Arendonk, Kyle J ^a   Knudson, Matthew J ^a   Austin, J Christopher ^a   Cooper, Christopher S ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYBUTYNIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CAPACITY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONSTIPATION; DELAYED DRUG RELEASE; DRUG EFFICACY; DRUG ERUPTION; DRUG FORMULATION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLUSHING; HEAT INTOLERANCE; HUMAN; MALE; PRIORITY JOURNAL; RESIDUAL URINE; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT DURATION; URINE INCONTINENCE; UROFLOWMETRY; XEROSTOMIA;

CHILD; CHILD, PRESCHOOL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MANDELIC ACIDS; MUSCARINIC ANTAGONISTS; RETROSPECTIVE STUDIES; URINARY INCONTINENCE; URODYNAMICS;

EID: 33750322817     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.04.034     Document Type: Article

References (13)

1. Sureshkumar P., Craig J.C., Roy L.P., et al. Daytime urinary incontinence in primary school children: a population-based survey. J Pediatr 137 (2000) 814-818
2. Hoebeke P., Van Laecke E., Van Camp C., et al. One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int 87 (2001) 575-580
3. Nijman R.J. Classification and treatment of functional incontinence in children. BJU Int 85 suppl 3 (2000) 37-42
4. Sureshkumar P., Bower W., Craig J.C., et al. Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials. J Urol 170 (2003) 196-200
5. Siddiqui M.A.A., Perry C.M., and Scott L.J. Oxybutynin extended release: a review of its use in the management of overactive bladder. Drugs 64 (2004) 885-912
6. Van Arendonk K.J., Austin J.C., Boyt M.A., et al. Frequency of wetting is predictive of response to anticholinergic treatment of children with overactive bladder. Urology 67 (2006) 1049-1054
7. Youdim K., and Kogan B.A. Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology 59 (2002) 428-432
8. Erickson B.A., Austin J.C., Cooper C.S., et al. Polyethylene glycol 3350 for constipation in children with dysfunctional elimination. J Urol 170 (2003) 1518-1520
9. Kaefer M., Zurakowski D., Bauer S.B., et al. Estimating normal bladder capacity in children. J Urol 158 (1997) 2261-2264
10. Versi E., Appell R., Mobley D., et al. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. Obstet Gynecol 95 (2000) 718-721
11. Anderson R.U., Mobley D., Blank B., et al. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. J Urol 161 (1999) 1809-1812
12. Gleason D.M., Susset J., White C., et al. Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence. Urology 54 (1999) 420-423
13. Franco I., Horowitz M., Grady R., et al. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction. J Urol 173 (2005) 221-225